Metraipolis › archive › dc_706cb59d7b48
Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer — Europe PMC PMID:42239517
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42239517
- DOI
- 10.3389/fphar.2026.1758062
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T15:12:44.247Z
- SHA-256 of the archived text
115a74ff3a455d8d733b4d5e7f1641e59fc7bcf31b9fc052c367fe2a0a37642e- Stable URL of this page
https://metraipolis.com/documento/dc_706cb59d7b48
How to cite
Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer — Europe PMC PMID:42239517 — Europe PMC (en), https://europepmc.org/article/MED/42239517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_706cb59d7b48 (Metraipolis archive dc_706cb59d7b48, sha256 115a74ff3a455d8d733b4d5e7f1641e59fc7bcf31b9fc052c367fe2a0a37642e)
BibTeX
@misc{dc706cb59d7b48,
title = {Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer — Europe PMC PMID:42239517},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42239517},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_706cb59d7b48; sha256 115a74ff3a455d8d733b4d5e7f1641e59fc7bcf31b9fc052c367fe2a0a37642e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42239517. Agents can read the archived copy with the MCP tool read_document.